NuPathe Inc.

Quick facts

Phase 3 pipeline

• NP101 · Neurology
  NP101 is a selective serotonin 5-HT1F receptor agonist that reduces migraine pain by constricting cranial blood vessels and inhibiting neuropeptide release.
• NP101 - Sumatriptan iontophoretic transdermal patch · Neurology
  NP101 delivers sumatriptan through the skin via iontophoresis, a technique using electrical current to enhance transdermal penetration, allowing rapid absorption without needles or oral administration.

Phase 1 pipeline

• PROT-CL-NP101-015.01

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• NuPathe Inc. portfolio CI brief
• NuPathe Inc. pipeline updates RSS